Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage
- PMID: 11114736
- DOI: 10.1038/sj.onc.1203913
Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage
Abstract
The four members of the ErbB family of receptor tyrosine kinases (RTKs) mediate a variety of cellular responses to epidermal growth factor (EGF)-like growth factors, and serve as a model for the generation of both diversity and specificity in RTK signaling. Previous studies indicate that receptor-receptor interactions figure prominently in signaling through ErbB receptors. In addition to a role in receptor kinase activation, ligand-induced ErbB receptor homo- and heterodimerization is thought to account for the diversity of biological responses stimulated by EGF-like growth factors. Since each receptor has the potential to couple to different complements of signaling pathways, EGF-like ligands specify cellular response by dictating which pairs of receptors become activated. More recently evidence has been uncovered for ligand discrimination by individual ErbB receptor dimers; receptors appear to realize which ligand is binding and differentially respond through autophosphorylation site usage. These observations indicate that ligand stimulation of RTKs is not generic, and point to another layer in the ErbB signal diversification mechanism. The mechanistic implications of ligand discrimination are discussed.
Similar articles
-
Bivalence of EGF-like ligands drives the ErbB signaling network.EMBO J. 1997 Aug 15;16(16):4938-50. doi: 10.1093/emboj/16.16.4938. EMBO J. 1997. PMID: 9305636 Free PMC article.
-
Signal transduction and oncogenesis by ErbB/HER receptors.Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):903-13. doi: 10.1016/j.ijrobp.2003.06.002. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967450 Review.
-
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.Cancer Res. 2002 Jun 1;62(11):3151-8. Cancer Res. 2002. PMID: 12036928
-
Epidermal growth factor receptor (EGFR) signaling in cancer.Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27. Gene. 2006. PMID: 16377102 Review.
-
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.Growth Factors. 2006 Jun;24(2):121-36. doi: 10.1080/08977190600634373. Growth Factors. 2006. PMID: 16801132 Review.
Cited by
-
Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice.PLoS One. 2012;7(8):e42805. doi: 10.1371/journal.pone.0042805. Epub 2012 Aug 9. PLoS One. 2012. PMID: 22912742 Free PMC article.
-
Prediction of functional phosphorylation sites by incorporating evolutionary information.Protein Cell. 2012 Sep;3(9):675-90. doi: 10.1007/s13238-012-2048-z. Epub 2012 Jul 16. Protein Cell. 2012. PMID: 22802047 Free PMC article.
-
Differential association of EphA2 intracellular regions in biased signaling.J Biol Chem. 2025 Apr;301(4):108383. doi: 10.1016/j.jbc.2025.108383. Epub 2025 Mar 4. J Biol Chem. 2025. PMID: 40049409 Free PMC article.
-
The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis.J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):393-406. doi: 10.1023/a:1014730829872. J Mammary Gland Biol Neoplasia. 2001. PMID: 12013529 Review.
-
EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.Cell. 2017 Oct 19;171(3):683-695.e18. doi: 10.1016/j.cell.2017.09.017. Epub 2017 Oct 5. Cell. 2017. PMID: 28988771 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous